Compound Summary


flutamide
  Compound Information
 flutamide

Compound Name:

flutamide

Compound CID:

3397

Synonyms:

flutamide

13311-84-7

Eulexin

Niftolide

Niftholide

More...

Iupac Name:

2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide

InChI:

InChI=1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)

InChIKey:

MKXKFYHWDHIYRV-UHFFFAOYSA-N

Canonical Smiles:

CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F

Isomeric Smiles:

CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F

Molecular Weight:

276.21

Molecular Formula:

C11H11F3N2O3

  Compound Structure
 2D Structure:
 3D Structure:
  Computed Properties
 flutamide

Molecular Weight:

276.21

Molecular Formula:

C11H11F3N2O3

Hydrogen Bond Donor Count:

1

Hydrogen Bond Acceptor Count:

6

Rotatable Bond Count:

2

Heavy Atom Count:

19

Complexity:

352

  Synonyms
 flutamide

flutamide flutamide

flutamide

13311-84-7

Eulexin

Niftolide

Niftholide

2-Methyl-N-4-nitro-3-(trifluoromethyl)phenylpropanamide

Sch 13521

NFBA

niftolid

Drogenil

Flutamin

Cebatrol, veterinary

Flutamida

Flutamidum

4-Nitro-3-trifluoromethylisobutyranilide

Sch-13521

2-Methyl-N-(4-nitro-3-trifluoromethylphenyl)propanamide

N-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)ISOBUTYRAMIDE

Propanamide, 2-methyl-N-4-nitro-3-(trifluoromethyl)phenyl-

SCH13521

MFCD00072009

NSC 215876

Flutamide (Eulexin)

alpha,alpha,alpha-Trifluoro-2-methyl-4-nitro-m-propionotoluidide

UNII-76W6J0943E

CHEMBL806

4-Nitro-3-(trifluoromethyl)isobutyranilide

CHEBI:5132

Propanamide, 2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-

76W6J0943E

NSC-215876

NCGC00015452-09

Eulexine

Chimax

4-Nitro-3-trifluoromethylisobutyramilide

CAS-13311-84-7

Hams F-12 medium

Flutamidum INN-Latin

DSSTox_CID_11121

DSSTox_RID_78899

DSSTox_GSID_32004

Flutamida INN-Spanish

Flutamide USP25

Prostandril

Odyne

SMR000058187

Eulexin (TN)

CCRIS 7246

m-Propionotoluidide,.alpha.,.alpha.-trifluoro-

SR-01000075888

N-4-Nitro-3-(trifluoromethyl)phenylisobutyramide

EINECS 236-341-9

BRN 2157663

.alpha.,.alpha.-Trifluoro-2-methyl-4-nitro-m-propionotoluidide"

m-Propionotoluidide,.alpha.,.alpha.-trifluoro-2-methyl-4-nitro-"

4-Nitro-3-(trifluoromethyl)isobutyranilide

Flutamide USAN:USP:INN:BAN

Flutamide,(S)

Prestwick_228

NK-601

ACMC-20hidt

Spectrum_001210

2-Methyl-N-4-nitro-3-(trifluoromethyl)phenylpropionamide

CPD000058187

Prestwick0_000180

Prestwick1_000180

Prestwick2_000180

Prestwick3_000180

Spectrum2_001201

Spectrum3_001421

Spectrum4_000829

Spectrum5_001450

Lopac-F-9397

F0663

Flutamide (pubertal study)

F 9397

SCHEMBL3934

Lopac0_000557

BSPBio_000079

BSPBio_003122

KBioGR_001377

KBioSS_001690

MLS000069634

MLS001065596

MLS002548892

DivK1c_000459

SPECTRUM1500995

SPBio_000982

SPBio_002000

Flutamide (JP17/USP/INN)

BPBio1_000087

GTPL6943

DTXSID7032004

SCHEMBL12932289

HMS501G21

KBio1_000459

KBio2_001690

KBio2_004258

KBio2_006826

KBio3_002342

NINDS_000459

HMS1568D21

HMS1921O16

HMS2090I18

HMS2092O14

HMS2095D21

HMS2230P19

HMS3259I03

HMS3261P15

HMS3373C12

HMS3655G22

HMS3712D21

Pharmakon1600-01500995

AMY32524

BCP23006

HY-B0022

ZINC3812944

Tox21_110154

Tox21_202169

Tox21_300536

Tox21_500557

BDBM50131270

CCG-39105

m-Propionotoluidide, 2-methyl-4-nitro-alpha,alpha,alpha-triflouro-

NSC147834

NSC215876

NSC757817

s1908

SBB006930

AKOS001025465

AKOS025243203

m-Propionotoluidide, .alpha.,.alpha.,.alpha.-trifluoro-2-methyl-4-nitro-

Tox21_110154_1

AB02835

DB00499

KS-5091

LP00557

MCULE-7498839065

NC00451

NSC-147834

NSC-757817

SDCCGSBI-0050540.P004

IDI1_000459

NCGC00015452-01

NCGC00015452-02

NCGC00015452-03

NCGC00015452-04

NCGC00015452-05

NCGC00015452-06

NCGC00015452-07

NCGC00015452-08

NCGC00015452-10

NCGC00015452-11

NCGC00015452-12

NCGC00015452-13

NCGC00015452-14

NCGC00015452-15

NCGC00015452-16

NCGC00015452-19

NCGC00015452-20

NCGC00015452-32

NCGC00091460-01

NCGC00091460-02

NCGC00091460-03

NCGC00091460-04

NCGC00091460-05

NCGC00091460-06

NCGC00091460-07

NCGC00091460-08

NCGC00091460-09

NCGC00254495-01

NCGC00259718-01

NCGC00261242-01

AC-24192

BF166239

ST058409

SY036411

SBI-0050540.P003

AB0005010

DB-042163

3-Trifluoromethyl-4-Nitro-Isobutyranilide

AB00052188

EU-0100557

FT-0626493

FT-0668764

SW196536-4

4-nitro-3-trifluoromethylisobutyranilide

C07653

D00586

J10037

AB00052188-09

AB00052188_10

AB00052188_11

311F847

A806562

Q418669

Q-201131

SR-01000075888-1

SR-01000075888-6

SR-01000075888-7

SR-01000075888-9

BRD-K28307902-001-05-0

Flutamide, certified reference material, TraceCERT(R)

Z56755651

a,a,a-Trifluoro-2-methyl-4-nitro- m-propionotoluidide

Flutamide, European Pharmacopoeia (EP) Reference Standard

2-Methyl-N-4-nitro-3-(trifluoromethyl)phenylpropanamide #

Flutamide, United States Pharmacopeia (USP) Reference Standard

2-methyl-N-4-nitro-3-(trifluoromethyl)phenylpropanamide;Flutamide

alpha,alpha,alpha-trifluoro-2-methyl-4-nitro-m-propionotoluidide"

.alpha.,.alpha.,.alpha.-Trifluoro-2-methyl-4-nitro-m-propionotoluidide"

m-Propionotoluidide, 2-methyl-4-nitro-.alpha.,.alpha.,.alpha.-trifluoro-"

m-Propionotoluidide, alpha,alpha,alpha-trifluoro-2-methyl-4-nitro- (8CI)

Flutamide for system suitability, European Pharmacopoeia (EP) Reference Standard

37209-54-4

  Experimental Data
 flutamide

Species Dose Unit Control(Avg days) Treatment(Avg days) Avg/Med Lifespan Change(%) Control(Max days) Treatment(Max days) Max Lifespan Change(%) Significant Strain Gender PubMed Avg/Med Lifespan Change tab
Caenorhabditis elegans 33.000000000000000 umol/L -19.000000000000000 NS N2 24134630 Inactive
  Experimental Data Visualization
 flutamide

  Statistics Data
 flutamide

Species Avg/Med Lifespan Change(%) Max Lifespan Change(%) Count Reference Count Data point
Caenorhabditis elegans -19.000000000000000 1 1
  Statistics Data Visualization
 flutamide